secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGIS CORP (RGS)
CIK:        0000716643
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0000716643-22-000023
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regis appoints Matthew Doctor as permanent President and CEO, effective May 5, 2022
--------------------------------------------------------------------------------

- Matthew Doctor, 35, appointed President & CEO and director; had been interim CEO since Dec 2021.
- Base salary $600K/yr, target bonus 125% of base, max payout 225%; granted options for 875,000 shares.
- Options vest 20% on 1st anniversary, 20% on 2nd, 60% on 3rd; exercise price = closing price on grant date.
- Doctor previously EVP & Chief Strategy Officer at Regis, earlier at Restaurant Brands International and J.P. Morgan.
- Board chair David Grissen: 'Matt has stabilized the team, built trust with franchisees, laid groundwork for future.'

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/0000716643-22-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/716643/000071664322000023/rgs-20220504.htm
  HTML page:      https://secwatch.observer/filing/0000716643-22-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer